| ABCB1 | ATP-binding cassette sub-family B member 1 |
| ALL | acute lymphoblastic leukemia |
| Bcr-Abl | breakpoint cluster region-Abelson |
| Btk | Bruton’s tyrosine kinase |
| CML | chronic myeloid leukemia |
| c-Src | cellular-sarcoma tyrosine kinase |
| DIPEA | N,N-diisopropylethylamine |
| EMA | European Medicines Agency |
| FDA | Food and Drug Admnistration |
| FRET | fluorescence resonance energy transfer |
| GBM | glioblastoma multiforme |
| HRI | hydrophobic region I |
| HTS | high-throughput screening |
| NB | neuroblastoma |
| NCEs | new chemical entities |
| PDGFR | platelet derived growth factor receptor |
| Ph+ | Philadelphia chromosome–positive |
| RET | REarranged during Transfection |
| SFK | Src family kinase |
| SH | Src homology |
| STK | serine/threonine kinase |
| TK | tyrosine kinase |
| VEGFR | vascular endothelial growth factor |